Cenra Inc. (TPE:3716)
Taiwan · Delayed Price · Currency is TWD 32.30
+0.10 (0.31%)
At close: Apr 24, 2026
Cenra Revenue
In the year 2025, Cenra had annual revenue of 8.57B TWD, down -3.91%. Cenra had revenue of 2.15B in the quarter ending December 31, 2025, a decrease of -5.03%.
Revenue
8.57B
Revenue Growth
-3.91%
P/S Ratio
0.55
Revenue / Employee
15.81M
Employees
542
Market Cap
4.72B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 8.57B | -348.78M | -3.91% |
| Dec 31, 2024 | 8.92B | 344.17M | 4.01% |
| Dec 31, 2023 | 8.57B | 118.21M | 1.40% |
| Dec 31, 2022 | 8.46B | 507.51M | 6.38% |
| Dec 31, 2021 | 7.95B | -232.06M | -2.84% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Lotus Pharmaceutical | 20.51B |
| PharmaEssentia | 15.63B |
| Medigen Biotechnology | 1.58B |
| SciVision Biotech | 886.62M |
| Easywell Biomedicals | 597.41M |
| Pharmosa Biopharm | 67.27M |
| Caliway Biopharmaceuticals | 38.04M |
| ACRO Biomedical | 36.50M |